74 filings
Page 4 of 4
8-K
5f2 pahbsj72
14 Mar 18
Other Events
12:00am
8-K
oebzpd2
5 Mar 18
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
12:00am
8-K
isxx f3o39y0i3nmhx11
16 Nov 17
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
12:00am
8-K
hri48iclez9u656
5 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
7sehyhxx1wgxj2
21 Sep 17
Regulation FD Disclosure
12:00am
8-K
ecs7 9g2vzudx1a9wn4
18 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
mtwoe 3ylfs259lmo3
10 Jul 17
Other Events
12:00am
8-K
jxblrjy7w70
23 Jun 17
Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
12:00am
8-K
tqv98mamu2
21 Jun 17
Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
7yhfuj8u 25xgr
15 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5titvw
23 May 17
Other Events
12:00am
8-K
32yjjemi
21 Nov 16
Spring Bank Pharmaceuticals Announces Financing of $15 Million
12:00am
8-K
jhrs2sk
29 Jul 16
Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors
12:00am
8-K
8xpuq
13 May 16
Unregistered Sales of Equity Securities
12:00am